Dysfunctional Regulatory T-Lymphocytes Promote Inflammation and Adverse Cardiac Remodeling in Chronic Ischemic Heart Failure

被引:0
|
作者
Bansal, Shyam S.
Goel, Mehak
Ismahil, Mohamed Ameen
Hamid, Tariq
Zhong, Hai
Wu, Yixin
Prabhu, Sumanth D.
机构
关键词
Heart failure; Left ventricular remodeling; Regulatory T-cells; Adaptive immune system; Immune mechanisms;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
18821
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Azithromycin Therapy Reduces Cardiac Inflammation and Mitigates Adverse Cardiac Remodeling After Myocardial Infarction: Potential Therapeutic Strategy in Ischemic Heart Disease
    Al-Darraji, Ahmed
    Haydar, Dalia
    Chelvarajan, Lakshman
    Tripathi, Himi
    Levitan, Bryana
    Ahmed, Ahmed E.
    Ye, Shaojing
    Feola, David
    Abdel-Latif, Ahmed
    CIRCULATION, 2017, 136
  • [32] The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction
    Hammer, Andreas
    Sulzgruber, Patrick
    Koller, Lorenz
    Kazem, Niema
    Hofer, Felix
    Richter, Bernhard
    Blum, Steffen
    Huelsmann, Martin
    Wojta, Johann
    Niessner, Alexander
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [33] Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease
    Al-Darraji, Ahmed
    Haydar, Dalia
    Chelvarajan, Lakshman
    Tripathi, Himi
    Levitan, Bryana
    Gao, Erhe
    Venditto, Vincent J.
    Gensel, John C.
    Feola, David J.
    Abdel-Latif, Ahmed
    PLOS ONE, 2018, 13 (07):
  • [34] The Effects of Cardiac Resynchronization Pacing with Different Site Combinations on Cardiac Performance and Ventricular Remodeling in Minipigs with Chronic Ischemic Heart Failure
    Fu Xianghua
    Liu Xiaokun
    Ma Ning
    Zhang Jing
    Jia Xinwei
    CIRCULATION, 2010, 122 (02) : E232 - E233
  • [35] Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling
    Teja Devarakonda
    Juan Valle Raleigh
    Adolfo G. Mauro
    Johana M. Lambert
    Lauren Ashley Cowart
    Fadi N. Salloum
    Scientific Reports, 12
  • [36] Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling
    Devarakonda, Teja
    Valle Raleigh, Juan
    Mauro, Adolfo G.
    Lambert, Johana M.
    Cowart, Lauren Ashley
    Salloum, Fadi N.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [37] Repeated Remote Ischemic Conditioning Inhibits Cardiac Remodeling with Chronic Heart Failure after Myocardial Infarction in Rats
    Yamaguchi, Takehiro
    Izumi, Yasukatsu
    Yamazaki, Takanori
    Nakamura, Yasuhiro
    Hanatani, Akihisa
    Shimada, Kenei
    Yoshiyama, Minoru
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S137 - S137
  • [38] GUT BACTERIA MODULATE T CELL RESPONSES AND ADVERSE CARDIAC REMODELING IN PRESSURE OVERLOAD INDUCED HEART FAILURE
    Carrillo-Salinas, Francisco J.
    Ngwenyama, Njabulo
    Anastasiou, Marina
    Kaur, Kuljeet
    Aronovitz, Mark
    Alcaide, Pilar
    FASEB JOURNAL, 2019, 33
  • [39] TNFR1 Regulates Cellular Proliferation And Not Pathogenicity Of Cd4+ T-lymphocytes During Ischemic Heart Failure
    Kumar, Vinay
    Rosenzweig, Rachel
    Asalla, Suman
    Nehra, Sarita
    Prabhu, Sumanth D.
    Bansal, Shyam S.
    CIRCULATION RESEARCH, 2022, 131
  • [40] MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease
    Martinez, Eliana C.
    Lilyanna, Shera
    Wang, Peipei
    Vardy, Leah A.
    Jiang, Xiaofei
    Armugam, Arunmozhiarasi
    Jeyaseelan, Kandiah
    Richards, Arthur Mark
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 112 : 27 - 39